scholarly journals Assessment of disaster preparedness at general hospitals in Al-Madinah Al-Munawarah Province, Western Region of Saudi Arabia

2021 ◽  
Vol 42 (5) ◽  
pp. 537-542
Author(s):  
Anas Khan ◽  
Jalal Alowais ◽  
Abdullah Nofal ◽  
Tareef Alama
2020 ◽  
Vol 2 (2) ◽  
pp. 13-23
Author(s):  
Mohammed Alghamdi ◽  
Nasser Aljuhani ◽  
Afrah AL- Somali ◽  
Saeed Alzahrani ◽  
Rashed Alotaibi ◽  
...  

Background The use of hydroxychloroquine in coronavirus disease (COVID-19) pandemic raised significant concerns as regards safety and efficacy in hospitalized patients. The objective was to examine the effect of hydroxychloroquine on clinical improvement and mortality among hospitalized patients with COVID-19. Methods A prospective cohort study was conducted at four general hospitals in the Western region, Saudi Arabia. Patients who had absolute or relative contraindication for using hydroxychloroquine were excluded. Patients concomitantly receiving other medications including azithromycin, antivirals, and supportive treatment were not excluded. Results A total 267 patients were included in the current analysis; 185 (69.3%) on hydroxychloroquine and 82 (30.7%) on non-hydroxychloroquine treatments. The average age was 46.0±13.3 years and 78.3% of the patients were males. Approximately 95.9% of the patients were symptomatic with mild (50.6%), moderate (32.6%), severe (8.2%), or ARDS symptoms (4.5%). Compared with no hydroxychloroquine, those on hydroxychloroquine had significantly longer length of stay (11.5±7.1 versus 7.8±4.3 days, p<0.001), more ICU admission (22.7% versus 9.8%, p=0.012), and more intubation (12.4% versus 3.7%, p=0.026). Improvement of symptoms (84.3% versus 81.7%, p=0.595) and hospitalization death (7.0% versus 1.2%, p=0.071) were not significantly different between groups. With exception of length of stay, the association of hydroxychloroquine with the above negative outcomes disappeared after adjustment for several factors including disease severity and concomitant use of azithromycin. Conclusions Hydroxychloroquine is not associated with better improvement of symptoms compared with other treatments. Moreover, it is associated with longer length of stay but not mortality or ICU admission in adjusted analysis.


Author(s):  
Abdulmalik Alghamdi ◽  
Mohammed Alzahrani ◽  
Abdulla Alhamami ◽  
Adel Altalhi ◽  
Ali Alkhathami ◽  
...  

Author(s):  
Abdulmajeed Alrefaei ◽  
Ahmed Ashoor ◽  
Ibrahim Alzahrani ◽  
Ibrahim Tarbiyyah ◽  
Muath Alrehily ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
pp. 25-33
Author(s):  
Mohammed G. Alsaedi ◽  
Bader S. AlQahtani ◽  
Anhar Khalid Zahrani ◽  
Shaima E. Alshareef ◽  
Khlood A. Alzubaidy ◽  
...  

Introduction: Ocular manifestations, such as conjunctivitis, redness, and tearing, were reported in patients with Coronavirus Disease 2019 (COVID-19). Objective: To investigate the level of knowledge, attitude, and practice about the ocular manifestations of COVID-19 and protective eye measures among the general population in the western region of Saudi Arabia. Methods: A cross-sectional study was conducted over two months with 800 participants from the general population and a 39-item online structured validated questionnaire using Google Forms. The collected data were analyzed using the SPSS program version 20 and a P-value <0.05 was considered statistically significant. Results and Discussion: Among the participants (n = 800), 71.9% were females, 50% were highly educated, and 61.8% had moderate incomes. The overall mean total knowledge score was 25.185 ± 3.774, with significant differences regarding age group, gender, and income. Most of the Saudi residents with high monthly incomes, especially females, were knowledgeable regarding the ocular manifestations of COVID-19 (25.0957 ± 3.4311). The average total knowledge, attitude, and practice score was 42.1419 ± 4.833, which was average (medium level), with significant differences regarding age group, gender, and income; a high mean was obtained from the age group >50–60, females, and high-income class. Conclusion: Detailed information about the epidemiology of COVID-19 and an understanding of emerging related health issues, such as ocular manifestations, should be empowered to the public while considering the least knowledgeable groups.


Sign in / Sign up

Export Citation Format

Share Document